logo
Median Technologies Reports 2025 Q1 Key Financial Indicators and Provides an Update on Q1 Key Operational Achievements

Median Technologies Reports 2025 Q1 Key Financial Indicators and Provides an Update on Q1 Key Operational Achievements

Yahoo24-04-2025

€6.0 million in Q1 2025 revenues, up 11% over Q1 2024
€74.8 million all-time high order backlog as of March 31, 2025
eyonis™ LCS pivotal RELIVE study met all key endpoints
U.S. FDA 510(k) filing on track for May 2025, filing for CE marking expected in June 2025.
eyonis™ LCS commercial launches as soon as year-end 2025 in U.S. and H1 2026 in Europe, pending regulatory approvals
Cash and cash equivalents at €8.8 million as of March 31, 2025
SOPHIA ANTIPOLIS, France, April 24, 2025--(BUSINESS WIRE)--Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, "Median" or "The Company"), manufacturer of eyonis™, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, releases today its Q1 2025 key financial indicators (unaudited) and provides an update on Q1 operational achievements.
Fredrik Brag, CEO and Founder of Median Technologies, commented: "The past quarter has seen the successful culmination of a transformational period for the Company: we are beginning to see the benefits of ongoing operational optimization in our iCRO business unit, and have recorded a €74.8 million all-time high order backlog. At the same time, after having met all the key endpoints in pivotal studies, RELIVE and REALITY, our lead Software as a Medical Device for lung cancer screening, eyonis™ LCS, has completed clinical development and is entering regulatory registration phase, the final step before commercialization. We expect our game-changing AI-driven SaMD will afford medical professionals' greater efficiency in lung cancer screening – while improving accuracy – to save many lives. Our timing is perfect as the U.S. and the rest of the world are moving now to increase the number of lifesaving lung cancer screenings performed each year. The math is simple, healthcare systems that increase screening capacity, will catch lung cancer early, when it can still be cured; and this will benefit not only the patients we serve but also avoid the tremendous costs of late-stage lung cancer treatment."
eyonis™ LCS SaMD: AI-driven innovation for Lung Cancer Screening
Q1 2025 key achievements
On March 31, 2025, the Company announced the successful completion of RELIVE, the second pivotal study of eyonis™ LCS, Median's AI-driven Software as a Medical Device (SaMD) for computer aided detection and diagnosis (CADe/CADx) of lung cancer. RELIVE final results confirmed the safety and efficacy of eyonis™ LCS SaMD, successfully completing the studies required to achieve marketing authorizations in the US and Europe.
In addition, this March, Median Technologies successfully achieved ISO/IEC 27001:2022 and HDS V2.0 certifications for eyonis™ activities, highlighting the Company's commitment to best practices in information security, including Personal Health Information. The notoriously difficult to obtain ISO 27001:2022 certification (international) and HDS V2.0 certification (France) are key to successful marketing of Median's eyonis™ suite of SaMDs in the US, in Europe and worldwide. The certifications were granted following a rigorous independent audit.
ISO/IEC 27001 is the international standard for information security management and sets out a framework for all organizations to establish, implement, operate, monitor, review, maintain and continually improve an Information Security Management System (ISMS). HDS (Hébergeurs de Données de Santé / Health Data Hosting) certification is strongly based on ISO/IEC 27001 requirements and is required for entities that host the personal health data governed by French laws and collected for delivering health services.
Upcoming key milestones
eyonis™ LCS' regulatory filings for U.S. FDA 510(k) clearance and CE marking, will be submitted in May and June, respectively. Consequently, given normal review times, Median continues to expect eyonis™ LCS' FDA 510(k) clearance in Q3 2025 and CE marking in Q1 2026, as previously communicated.
Median eyonis™ teams are preparing for eyonis™ LCS commercial launch in the US, shortly after FDA clearance, around the end of 2025.
iCRO: Q1 2025 revenue at €6.0 million confirming return to revenue growth, order backlog at an all-time high of €74.8 million
Median revenue during the period stemmed entirely from the iCRO Business Unit, which provides imaging services to measure drug efficacy in industry-sponsored oncology trials.
Q1 2025 revenue totaled €6.0 million, up 11%, compared to €5.4 million revenue during the same period in 2024, building on the revenue growth acceleration seen during the second half of 2024.
On March 31, 2025, the order backlog1 hit its highest level ever reached at €74.8 million, vs €71.0 million as of December 31, 2024, i.e., a 5.4% increase primarily driven by new awards and contracts from the undisclosed Top 3 pharma company, to which Median became preferred vendor in May 2024.
Cash and cash equivalents as of March 31, 2025
On March 31, 2025, cash and cash equivalents stood at €8.8 million, versus €8.1 million on December 31, 2024. In Q1 2025, the Company's cash position was strengthened with the receipt of €4 million from the first tranche of the equity line completed with IRIS and announced in January 2025 and with the advanced payment of the 2024 French research and innovation tax credit for an amount of €1.4 million.
Median and the European Investment Bank (EIB) have extended the maturity of the loan granted in 2020 by six months, i.e., until October 2025. Furthermore, as previously announced, and communicated on the EIB website, the Company is working with the European Investment Bank on finalizing in the coming weeks, an agreement for a new financing facility of up to €37.5 million to enable the regulatory and commercialization activities of eyonis™ LCS. Upon completion of the agreement, which would trigger the drawdown of a first tranche, the Company estimates that it will be able to cover its financing needs until Q4 2025.
Subsequent tranches of the above-mentioned EIB financing facility will be made available upon completion of certain undisclosed milestones. Fulfillment of these milestones, enabling further drawdowns, should contribute to extending the Company's cash runway until at least the end of 2026.
Next financial release on April 29, 2025, after the market closing:2024 Financial Report
About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis™, an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are not historical facts. They include projections and estimates as well as the assumptions on which these are based, statements concerning projects, objectives, intentions, and expectations with respect to future financial results, events, operations, services, product development and potential, or future performance.
These forward-looking statements can often be identified by the words "expects," "anticipates," "believes," "intends," "estimates" or "plans" and any other similar expressions. Although Median's management believes that these forward-looking statements are reasonable, investors are cautioned that forward-looking statements are subject to numerous risks and uncertainties, many of which are difficult to predict and generally beyond the control of Median Technologies, that could cause actual results and events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements.
All forward-looking statements in this press release are based on information available to Median Technologies as of the date of the press release. Median Technologies does not undertake to update any forward-looking information or statements, subject to applicable regulations, in particular Articles 223-1 et seq. of the General Regulation of the French Autorité des Marchés Financiers.
____________________
1 The order backlog is the sum of orders received but not yet fulfilled. An increase or decrease in the order backlog corresponds to the order intake of the reporting period, net of invoiced services, completed or cancelled contracts, and currency impact for projects in foreign currency (re-evaluated at the exchange rate on closing date). Orders are booked once the customer confirms, in writing, its retention of the Company's services for a given project. The contract is usually signed a few months after written confirmation.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250424569996/en/
Contacts
MEDIAN TECHNOLOGIESEmmanuelle LeyguesVP, Corporate Marketing & Financial Communications+33 6 10 93 58 88emmanuelle.leygues@mediantechnologies.com Investors - SEITOSEI ACTIFINGhislaine Gasparetto+33 6 21 10 49 24ghislaine.gasparetto@seitosei-actifin.com U.S. media & investors - COHESION BUREAUChris Maggos+41 79 367 6254chris.maggos@cohesionbureau.com Press – ULYSSE COMMUNICATIONBruno Arabian+33 6 87 88 47 26barabian@ulysse-communication.com Nicolas Entz+33 6 33 67 31 54nentz@ulysse-communication.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

KI Celebrates Best of NeoCon 2025 Recognition for the Cogni Classroom Chair
KI Celebrates Best of NeoCon 2025 Recognition for the Cogni Classroom Chair

Yahoo

time35 minutes ago

  • Yahoo

KI Celebrates Best of NeoCon 2025 Recognition for the Cogni Classroom Chair

Reinforcing KI's Commitment to Innovation in Flexible and Active Learning Spaces. GREEN BAY, Wis., June 09, 2025--(BUSINESS WIRE)--KI is proud to announce its success at this year's Best of NeoCon awards competition, with one of its newest innovations receiving Silver honors at North America's most prestigious commercial interiors awards program. This recognition reinforces KI's commitment to thoughtful, flexible and forward-thinking design solutions for today's evolving learning, working and healing environments. "We are incredibly honored to be recognized by the Best of NeoCon judges for the Cogni Classroom Chair," said Tony Besasie, chief marketing and sales officer at KI. "The Best of NeoCon Silver Award validates the passion and purpose our design and engineering teams bring to each product we develop. Every piece reflects KI's belief in creating intelligent, adaptable solutions that meet the real needs of our customers across industries." Cogni™ classroom seating redefines the student experience with intuitive support, durable construction and the flexibility required in today's active learning spaces. Designed with ergonomic comfort and motion in mind, Cogni encourages natural movement to promote student engagement and focus. "With Cogni, we set out to rethink what classroom seating could be," said Besasie. "We know that movement is essential to focus and learning. Cogni encourages that movement—offering intuitive comfort that adapts to the learner, not the other way around. It's a thoughtful response to how students truly engage in today's classrooms." This recognition comes as KI marks its final NeoCon showcase at The Mart before moving to its new showroom in Fulton Market in 2026. "As we reflect on our legacy at The Mart and look ahead to our future at Fulton Market, it is especially meaningful to be honored this year," said Besasie. "This moment encapsulates KI's evolution, rooted in design excellence and always looking forward." ABOUT KI KI manufactures innovative furniture for education, healthcare, government and corporate markets. The employee-owned company is headquartered in Green Bay, Wisconsin, with sales and manufacturing facilities worldwide. KI tailors products and service solutions to the specific needs of each customer through its unique design and manufacturing philosophy. For more information, visit View source version on Contacts Media Contact: Shelly SchumacherVice President, Public RelationsNelson Schmidt Inc.262-305-1713sschumacher@

Fortune Media and Great Place To Work Name Agiloft to 2025 Fortune Best Workplaces in the Bay Area
Fortune Media and Great Place To Work Name Agiloft to 2025 Fortune Best Workplaces in the Bay Area

Yahoo

time35 minutes ago

  • Yahoo

Fortune Media and Great Place To Work Name Agiloft to 2025 Fortune Best Workplaces in the Bay Area

The leader in CLM invests in employee experiences, from remote flexibility to professional development, driving both workplace satisfaction and exceptional customer outcomes REDWOOD CITY, Calif., June 9, 2025 /PRNewswire/ -- Agiloft, the global value leader in data-first contract lifecycle management (CLM), announced today Great Place To Work® and Fortune magazine have honored Agiloft as one of this year's Best Workplaces in the Bay Area. This is the first time the company has been named to this prestigious list. Earning a spot means that Agiloft has surpassed rigorous benchmarks, establishing itself as one of the best workplaces in the San Francisco Bay region. To determine the Fortune Best Workplaces in the Bay Area™ List, Great Place To Work collected nearly 85,000 confidential survey responses from employees at eligible companies via its proprietary platform. Companies were ranked based on their ability to offer consistently positive experiences, building trust with leaders, colleagues, and the overall organization. "Our philosophy has always been simple: when employees are supported, engaged, and empowered, they can deliver extraordinary experiences for our customers," said May Quock, VP of People Operations at Agiloft. "We are so grateful for our dedicated employees who have made us a part of this list. It is a reflection of our team's dedication and the meaningful culture we continue to build together." The Best Workplaces in the Bay Area list is highly competitive. Survey responses reflect a comprehensive picture of the workplace experience. Honorees were rewarded based on their ability to deliver positive outcomes for employees regardless of role or status within the organization. To be eligible for the list, companies must be Great Place To Work Certified™, have at least 10 U.S. employees, and be headquartered in the San Francisco Bay Area. "Congratulations to the Fortune Best Workplaces in the Bay Area," says Michael C. Bush, CEO at Great Place To Work. "These companies prove that prioritizing people leads to better performance, and that leaders who invest in their people are rewarded with more sustainable and profitable businesses." Earlier this year, Agiloft became Certified™ by Great Place To Work.® The certification is based entirely on what current employees say about their experience working at Agiloft, resulting in 88 percent of employees saying that Agiloft is a great place to work – 31 points higher than the average U.S. company. Agiloft believes great employee experiences drive superior customer experiences (EX=CX). The company offers a remote-first workplace, quarterly wellness days, Summer Fridays, and supports several employee resource groups. It also provides a strong personal and professional development program to help employees thrive. To view the entire Fortune Best Workplaces in the Bay Area™ 2025 List, visit here. Looking to grow your career at a company that puts its people first? Visit our careers page at About AgiloftAgiloft is the global value leader in data-first contract lifecycle management (CLM), offering the industry's only no-code platform with AI on the Inside™ to enhance efficiency, cut review times by up to 80%, and accelerate business. Its Data-first Agreement Platform (DAP) transforms contracts into strategic, data-rich assets, integrating with 1,000+ systems to drive decisions and efficiency. Trusted by brands like Alkermes, Balluff, and TaylorMade, Agiloft boasts a 96% renewal rate and 100% satisfaction for implementations. Backed by KKR, JMI Equity, and FTV Capital, Agiloft empowers businesses to drive smarter strategies, faster decision-making and game-changing competitive advantage. Learn more at About the Fortune Best Workplaces in the Bay AreaGreat Place To Work selected the Fortune Best Workplaces in the Bay Area List by surveying 1.3 million employees in the U.S., representing companies that collectively employ more than 8.4 million U.S. workers. Of those responses, nearly 85,000 were received from employees at companies that were eligible for the 2025 Fortune Best Workplaces in the Bay Area List and these rankings are based on their feedback. Companies earn eligibility by being Great Place To Work Certified™, having at least 10 U.S. employees, and having headquarters in the Bay Area. Read the full methodology. To get on this list next year, start here. About Great Place To WorkAs the global authority on workplace culture, Great Place To Work brings more than three decades of groundbreaking research and data to help every place become a great place to work for all. Its proprietary platform and Great Place To Work Model™ help companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified and receiving recognition on its coveted Best Workplaces™ lists. Follow Great Place To Work on LinkedIn, Twitter, and Instagram or visit and sign up for the newsletter to learn more. About FortuneFortune upholds a legacy of award-winning writing and trusted reporting for executives who want to make business better. Independently owned, with a global perspective and digital agility, Fortune tells the stories of a new generation of innovators, builders, and risk-takers. Online and in print, Fortune measures corporate performance through rigorous benchmarks and holds companies accountable. Fortune creates communities by convening true thought leaders and iconoclasts — those who shape industry, commerce, and society — through powerful and prestigious lists, events, and conferences, such as the iconic Fortune 500, the CEO Initiative and Most Powerful Women. For more information, visit Media ContactAngel DuanSenior Manager, Corporate Communications396010@ (650) 780-6741 ext. 5775 View original content: SOURCE Agiloft

KI Celebrates Best of NeoCon 2025 Recognition for the Cogni Classroom Chair
KI Celebrates Best of NeoCon 2025 Recognition for the Cogni Classroom Chair

Business Wire

timean hour ago

  • Business Wire

KI Celebrates Best of NeoCon 2025 Recognition for the Cogni Classroom Chair

GREEN BAY, Wis.--(BUSINESS WIRE)--KI is proud to announce its success at this year's Best of NeoCon awards competition, with one of its newest innovations receiving Silver honors at North America's most prestigious commercial interiors awards program. This recognition reinforces KI's commitment to thoughtful, flexible and forward-thinking design solutions for today's evolving learning, working and healing environments. "We are incredibly honored to be recognized by the Best of NeoCon judges for the Cogni Classroom Chair,' said Tony Besasie, chief marketing and sales officer at KI. Share 'We are incredibly honored to be recognized by the Best of NeoCon judges for the Cogni Classroom Chair,' said Tony Besasie, chief marketing and sales officer at KI. 'The Best of NeoCon Silver Award validates the passion and purpose our design and engineering teams bring to each product we develop. Every piece reflects KI's belief in creating intelligent, adaptable solutions that meet the real needs of our customers across industries.' Cogni™ classroom seating redefines the student experience with intuitive support, durable construction and the flexibility required in today's active learning spaces. Designed with ergonomic comfort and motion in mind, Cogni encourages natural movement to promote student engagement and focus. 'With Cogni, we set out to rethink what classroom seating could be,' said Besasie. 'We know that movement is essential to focus and learning. Cogni encourages that movement—offering intuitive comfort that adapts to the learner, not the other way around. It's a thoughtful response to how students truly engage in today's classrooms.' This recognition comes as KI marks its final NeoCon showcase at The Mart before moving to its new showroom in Fulton Market in 2026. 'As we reflect on our legacy at The Mart and look ahead to our future at Fulton Market, it is especially meaningful to be honored this year,' said Besasie. 'This moment encapsulates KI's evolution, rooted in design excellence and always looking forward.' ABOUT KI KI manufactures innovative furniture for education, healthcare, government and corporate markets. The employee-owned company is headquartered in Green Bay, Wisconsin, with sales and manufacturing facilities worldwide. KI tailors products and service solutions to the specific needs of each customer through its unique design and manufacturing philosophy. For more information, visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store